Table of Contents
Chapter 1. Methodology and Scope
1.1. Market Segmentation & Scope
1.1.1. Product
1.1.2. Usage
1.1.3. Capacity
1.1.4. End-use
1.1.5. Regional scope
1.1.6. Estimates and forecast timeline
1.2. Research Methodology
1.3. Information Procurement
1.3.1. Purchased database
1.3.2. GVR’s internal database
1.3.3. Secondary sources
1.3.4. Primary research
1.3.5. Details of primary research
1.4. Information or Data Analysis
1.5. Market Formulation & Validation
1.6. Model Details
1.7. List of Secondary Sources
1.8. List of Primary Sources
1.9. Objectives
Chapter 2. Executive Summary
2.1. Market Outlook
2.2. Segment Outlook
2.2.1. Product outlook
2.2.2. Usage outlook
2.2.3. Capacity Outlook
2.2.4. End-use outlook
2.2.5. Regional outlook
2.3. Competitive Insights
Chapter 3. Urinary Drainage Bags Market Variables, Trends & Scope
3.1. Market Lineage Outlook
3.1.1. Parent market outlook
3.1.2. Related/ancillary market outlook
3.2. Penetration & Growth Prospect Mapping
3.3. Market Dynamics
3.3.1. Market driver analysis
3.3.2. Market restraint analysis
3.4. Urinary Drainage Bags Market Analysis Tools
3.4.1. Industry Analysis – Porter’s
3.4.1.1. Supplier power
3.4.1.2. Buyer power
3.4.1.3. Substitution threat
3.4.1.4. Threat of new entrant
3.4.1.5. Competitive rivalry
3.4.2. PESTEL Analysis
3.4.2.1. Political landscape
3.4.2.2. Technological landscape
3.4.2.3. Economic Landscape
Chapter 4. Urinary Drainage Bags: Product Estimates & Trend Analysis
4.1. Urinary Drainage Bags Market: Key Takeaways
4.2. Urinary Drainage Bags Market: Movement & Market Share Analysis, 2022 & 2030
4.3. Large Bags
4.3.1. Large bags market estimates and forecasts, 2018 to 2030 (USD Million)
4.4. Leg Bags
4.4.1. Leg bags market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 5. Urinary Drainage Bags: Usage Estimates & Trend Analysis
5.1. Urinary Drainage Bags Market: Key Takeaways
5.2. Urinary Drainage Bags Market: Movement & Market Share Analysis, 2022 & 2030
5.3. Reusable
5.3.1. Reusable market estimates and forecasts, 2018 to 2030 (USD Million)
5.4. Disposable
5.4.1. Disposable market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 6. Urinary Drainage Bags: Capacity Estimates & Trend Analysis
6.1. Urinary Drainage Bags Market: Key Takeaways
6.2. Urinary Drainage Bags Market: Movement & Market Share Analysis, 2022 & 2030
6.3. 0-500 Ml Urinary Drainage Bags
6.3.1. 0-500 ml urinary drainage bags market estimates and forecasts, 2018 to 2030 (USD Million)
6.4. 500-1000 Ml Urinary Drainage Bags
6.4.1. 500-1000 ml urinary drainage bags market estimates and forecasts, 2018 to 2030 (USD Million)
6.5. 1000-2000 Ml Urinary Drainage Bags
6.5.1. 1000-2000 ml urinary drainage bags market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 7. Urinary Drainage Bags: End-use Estimates & Trend Analysis
7.1. Urinary Drainage Bags Market: Key Takeaways
7.2. Urinary Drainage Bags Market: Movement & Market Share Analysis, 2022 & 2030
7.3. Hospitals
7.3.1. Hospitals market estimates and forecasts, 2018 to 2030 (USD Million)
7.4. Clinics
7.4.1. Clinics market estimates and forecasts, 2018 to 2030 (USD Million)
7.5. Others
7.5.1. Other market estimates and forecasts, 2018 to 2030 (USD Million)
Chapter 8. Urinary Drainage Bags Market: Regional Estimates & Trend Analysis
8.1. Regional Outlook
8.2. Urinary Drainage Bags Market by Region: Key Marketplace Takeaway
8.3. North America
8.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.2. U.S.
8.3.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.3.3. Canada
8.3.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4. Europe
8.4.1. UK
8.4.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.2. Germany
8.4.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.3. France
8.4.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.4. Italy
8.4.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.5. Spain
8.4.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.6. Sweden
8.4.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.7. Norway
8.4.7.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.4.8. Denmark
8.4.8.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5. Asia Pacific
8.5.1. Japan
8.5.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.2. China
8.5.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.3. India
8.5.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.4. Australia
8.5.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.5. Thailand
8.5.5.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.5.6. South Korea
8.5.6.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6. Latin America
8.6.1. Brazil
8.6.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.2. Mexico
8.6.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.6.3. Argentina
8.6.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7. MEA
8.7.1. Saudi Arabia
8.7.1.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.2. South Africa
8.7.2.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.3. UAE
8.7.3.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
8.7.4. Kuwait
8.7.4.1. Market estimates and forecasts, 2018 – 2030 (Revenue, USD Million)
Chapter 9. Competitive Landscape
9.1. Recent Developments & Impact Analysis, By Key Market Participants
9.2. Market Participant Categorization
9.2.1. ConvaTec, Inc.
9.2.1.1. Company Overview
9.2.1.2. Financial performance
9.2.1.3. Product benchmarking
9.2.1.4. Strategic Initiatives
9.2.2. Cardinal Health
9.2.2.1. Company Overview
9.2.2.2. Financial performance
9.2.2.3. Product benchmarking
9.2.2.4. Strategic initiatives
9.2.3. Teleflex Incorporated
9.2.3.1. Company Overview
9.2.3.2. Financial performance
9.2.3.3. Product benchmarking
9.2.3.4. Strategic Initiatives
9.2.4. Coloplast
9.2.4.1. Company Overview
9.2.4.2. Financial performance
9.2.4.3. Product benchmarking
9.2.4.4. Strategic Initiatives
9.2.5. BD (C. R. Bard)
9.2.5.1. Company Overview
9.2.5.2. Financial performance
9.2.5.3. Product benchmarking
9.2.5.4. Strategic Initiatives
9.2.6. McKesson Medical-Surgical Inc.
9.2.6.1. Company Overview
9.2.6.2. Financial performance
9.2.6.3. Product benchmarking
9.2.6.4. Strategic initiatives
9.2.7. Amsino International, Inc.
9.2.7.1. Company Overview
9.2.7.2. Financial performance
9.2.7.3. Product benchmarking
9.2.7.4. Strategic initiatives
9.2.8. Flexicare Medical Limited
9.2.8.1. Company Overview
9.2.8.2. Financial performance
9.2.8.3. Product benchmarking
9.2.8.4. Strategic initiatives
9.2.9. Medline Industries, Inc.
9.2.9.1. Company Overview
9.2.9.2. Financial performance
9.2.9.3. Product benchmarking
9.2.9.4. Strategic initiatives
9.2.10. Manfred Sauer GmbH
9.2.10.1. Company Overview
9.2.10.2. Financial performance
9.2.10.3. Product benchmarking
9.2.10.4. Strategic initiatives
*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/